Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Latest filing published 15 Sept 2026 for Century Therapeutics, Inc., €2,761. Read the official filing
Filing timeline
BuySaleDouglas Carr
Insider track record
Disclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Douglas Carr: trading record in brief
Douglas Carr discloses dealings in Century Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 2 February 2023 to 14 September 2026, the count stands at 26 filings.
Every open-market trade on record is a sale: 19 sales worth €28k. The totals exclude 2 filings filed without an amount. Other entries cover 7 share grants. In 2026 alone, the filings show no purchases and 8 sales.
On 15 September 2026 came the latest disclosure, an open-market sale for €2,761 in Century Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas Carr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
1,658 shares@ US$1.93Common StockSEC:0001867173-26-000020:0
254 shares@ US$2.050.0001% mcap0.7% of flowCommon StockSEC:0001867173-26-000018:0
275 shares@ US$1.9770.0001% mcap0.7% of flowCommon StockSEC:0001867173-26-000016:0
1,654 sharesCommon StockSEC:0001867173-26-000014:0
249 sharesCommon StockSEC:0001867173-26-000012:0
7,043 shares@ US$2.54923.7% of flowCommon StockSEC:0001867173-26-000008:0
247 shares@ US$2.5360.8% of flowCommon StockSEC:0001867173-26-000006:0
323 shares@ US$1.8220.7% of flowCommon StockSEC:0001867173-26-000004:0
110,000 shares0Common StockSEC:0001867173-26-000002:0
257 shares@ US$0.5320.2% of flowCommon StockSEC:0001867173-25-000005:0
292 shares@ US$0.5860.2% of flowCommon StockSEC:0001867173-25-000003:0
263 shares@ US$0.500.2% of flowCommon StockSEC:0001062993-25-015526:0
296 shares@ US$0.5340.3% of flowCommon StockSEC:0001062993-25-013720:0
4,904 shares@ US$0.6225.3% of flowCommon StockSEC:0001062993-25-011429:0
295 shares@ US$0.550.3% of flowCommon StockSEC:0001062993-25-008772:0
1,240 shares@ US$0.6151.5% of flowCommon StockSEC:0001062993-25-005288:0
351 shares@ US$0.780.6% of flowCommon StockSEC:0001062993-25-001755:0
16,611 shares@ US$1.2640.7% of flowCommon StockSEC:0001062993-24-018338:0
289 shares@ US$1.8271.0% of flowCommon StockSEC:0001062993-24-014582:0
17,007 shares0Common StockSEC:0001062993-24-012312:0
257 shares@ US$3.1061.6% of flowCommon StockSEC:0001062993-24-009574:0
14,000 shares0Common StockSEC:0001062993-24-006185:0
643 shares@ US$3.8414.8% of flowCommon StockSEC:0001062993-24-002321:0
16,611 shares@ US$1.4949.5% of flowCommon StockSEC:0001062993-23-020090:0
120,846 shares0Common StockSEC:0001062993-23-011404:0
25 of 26 declarations
